ENZN
Price:
$0.08
Market Cap:
$5.94M
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.[Read more]
Industry
Biotechnology
IPO Date
1984-02-15
Stock Exchange
PNK
Ticker
ENZN
According to Enzon Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 8.00. This represents a change of 18.40% compared to the average of 6.76 of the last 4 quarters.
The mean historical PE Ratio of Enzon Pharmaceuticals, Inc. over the last ten years is -10.79. The current 8.00 PE Ratio has changed -7514.45% with respect to the historical average. Over the past ten years (40 quarters), ENZN's PE Ratio was at its highest in in the March 2021 quarter at 1.37K. The PE Ratio was at its lowest in in the June 2021 quarter at -644.50.
Average
-10.79
Median
-3.95
Minimum
-98.41
Maximum
70.87
Discovering the peaks and valleys of Enzon Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 459.77%
Maximum Annual PE Ratio = 70.87
Minimum Annual Increase = -1128.08%
Minimum Annual PE Ratio = -98.41
Year | PE Ratio | Change |
---|---|---|
2023 | 70.87 | -172.01% |
2022 | -98.41 | 81.59% |
2021 | -54.20 | 459.77% |
2020 | -9.68 | 4.07% |
2019 | -9.30 | -588.39% |
2018 | 1.90 | -13.11% |
2017 | 2.19 | -115.30% |
2016 | -14.33 | -1128.08% |
2015 | 1.39 | -16.54% |
2014 | 1.67 | -40.31% |
The current PE Ratio of Enzon Pharmaceuticals, Inc. (ENZN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-27.25
5-year avg
-20.15
10-year avg
-10.79
Enzon Pharmaceuticals, Inc.’s PE Ratio is greater than PMV Pharmaceuticals, Inc. (-1.73), greater than NewAmsterdam Pharma Company N.V. (-7.40), greater than Tempest Therapeutics, Inc. (-0.67), greater than IO Biotech, Inc. (-0.88), less than Molecular Pharmacology (USA), Ltd. (0), greater than Curative Biotechnology, Inc. (-1.82), less than Kineta, Inc. (0), greater than OncoVista Innovative Therapies, Inc. (-0.36), less than Neurobiological Technologies, Inc. (0), less than Polydex Pharmaceuticals Limited (0), less than Cyclacel Pharmaceuticals, Inc. (0), greater than Living Cell Technologies Limited (0), greater than MultiCell Technologies, Inc. (-0.05), greater than Institute of Biomedical Research Corp. (-3.61), greater than Health Sciences Group, Inc. (-0.10), greater than Mymetics Corporation (-0.08), less than Eliem Therapeutics, Inc. (0), greater than Molecular Partners AG (-0.03), greater than Opthea Limited (-2.42), greater than PureTech Health plc (-3.01), greater than Acrivon Therapeutics, Inc. Common Stock (-1.53), greater than null (-54.81), greater than null (-4.11),
Company | PE Ratio | Market cap |
---|---|---|
-1.73 | $84.49M | |
-7.40 | $1.62B | |
-0.67 | $25.00M | |
-0.88 | $77.74M | |
0 | $11.15K | |
-1.82 | $8.13M | |
0 | $7.05M | |
-0.36 | $558.34K | |
0 | $2.70K | |
0 | $6.82M | |
0 | $1.09M | |
0 | $7.17M | |
-0.05 | $50.01K | |
-3.61 | $9.60M | |
-0.10 | $187.09K | |
-0.08 | $303.76K | |
0 | $342.68M | |
-0.03 | $247.30M | |
-2.42 | $628.43M | |
-3.01 | $498.68M | |
-1.53 | $243.13M | |
-54.81 | $0 | |
-4.11 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enzon Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Enzon Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Enzon Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Enzon Pharmaceuticals, Inc. (ENZN)?
What is the highest PE Ratio for Enzon Pharmaceuticals, Inc. (ENZN)?
What is the 3-year average PE Ratio for Enzon Pharmaceuticals, Inc. (ENZN)?
What is the 5-year average PE Ratio for Enzon Pharmaceuticals, Inc. (ENZN)?
How does the current PE Ratio for Enzon Pharmaceuticals, Inc. (ENZN) compare to its historical average?